Structure–Activity Relationships in Salinomycin: Cytotoxicity and Phenotype Selectivity of Semi-synthetic Derivatives

Chemistry - A European Journal

Volumn 23, Issue 9, 2017, Pages 2077-2083

  Borgström, Björn ^a   Huang, Xiaoli ^a   Hegardt, Cecilia ^a   Oredsson, Stina ^a   Strand, Daniel ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cancer treatment; ionophores; phenotype selectivity; salinomycin; structure activity relationships

Indexed keywords

CARBOXYLATION; CELL CULTURE; CELL PROLIFERATION; DISEASES; KETONES; ONCOLOGY; STEM CELLS;

BREAST CANCER CELLS; CANCER STEM CELLS; DRUG RESISTANCE; MOLECULAR MECHANISM; SALINOMYCIN; SEMI-SYNTHETIC DERIVATIVES; SYNTHETIC STRATEGIES; TUMORIGENICITY;

IONOPHORES;

EID: 85002654584     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201603621     Document Type: Article

References (41)

1. A. Marusyk, V. Almendro, K. Polyak, Nat. Rev. Cancer 2012, 12, 323334.
2. L. V. Nguyen, R. Vanner, P. Dirks, C. J. Eaves, Nat. Rev. Cancer 2012, 12, 133–143;
3. T. Reya, S. J. Morrison, M. F. Clarke, I. L. Weissman, Nature 2001, 414, 105111.
4. M. Dean, T. Fojo, S. Bates, Nat. Rev. Cancer 2005, 5, 275284;
5. T. Oskarsson, E. Batlle, J. Massagué, Cell Stem Cell 2014, 14, 306321.
6. P. B. Gupta, T. T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R. A. Weinberg, E. S. Lander, Cell 2009, 138, 645659.
7. B. Borgström, X. Huang, M. Pota, C. Hegardt, S. Oredsson, D. Strand, Chem. Commun. 2013, 49, 9944.
8. X. Huang, B. Borgström, S. KempengrenC. Hegardt, D. Strand, S. Oredsson, Persson, Lo;, BMC Cancer 2016, 16, 145. DOI: 10.1186s12885-016-2142-3.
9. B. Borgström, E. Chygorin, X. Huang, S. Oredsson, D. Strand, ACS Med. Chem. Lett. 2016, 7, 635–640.
10. See for example:
11. D. Lu, M. Y. Choi, J. Yu, J. E. Castro, T. J. Kipps, D. A. Carson, Proc. Natl. Acad. Sci. USA 2011, 108, 13253–13257;
12. R. Riccioni, M. L. Dupuis, M. Bernabei, E. Petrucci, L. Pasquini, G. Mariani, M. Cianfriglia, U. Testa, Blood Cells Mol. Dis. 2010, 45, 8692;
13. J. R. Jangamreddy, S. Ghavami, J. Grabarek, G. Kratz, E. Wiechec, B.-A. Fredriksson, R. K. Rao Pariti, A. Cieślar-Pobuda, S. Panigrahi, M. J. Łos, Biochim. Biophys. Acta Mol. Cell Res. 2013, 1833, 20572069;
14. K. Ketola, M. Hilvo, T. Hyötylainen, A. Vuoristo, A.-L. Ruskeepää, M. Oresic, O. Kallioniemi, K. Iljin, Br. J. Cancer 2012, 106, 99106;
15. A. Managò, L. Leanza, L. Carraretto, N. Sassi, S. Grancara, R. Quintana-Cabrera, V. Trimarco, A. Toninello, L. Scorrano, L. Trentin, G. Semenzato, E. Gulbins, M. Zoratti, I. Szabò, Cell Death Differ. 2015, 22, e 1930. DOI:10.1038/cddis.2015.263;
16. D. Fuchs, V. Daniel, M. Sadeghi, G. Opelz, C. Naujokat, Biochem. Biophys. Res. Commun. 2010, 394, 1098–1104.
17. See for example:
18. M. Antoszczak, K. Popiel, J. Stefańska, J. Wietrzyk, E. Maj, J. Janczak, G. Michalska, B. Brzezinski, A. Huczyński, Eur J Med Chem. 2014, 76, 435444;
19. M. Antoszczak, E. Maj, J. Stefańska, J. Wietrzyk, J. Janczak, B. Brzezinski, A. Huczyński, Bioorg. Med. Chem. Lett. 2014, 24, 1724;
20. M. Antoszczak, G. Klejborowska, M. Kruszyk, E. Maj, J. Wietrzyk, A. Huczyński, Chem. Biol. Drug Des. 2015, 86, 1378–1386.
21. W. Zhang, J. Wu, B. Li, H. Wu, L. Wang, J. Hao, S. Wu, Q. Zhou, Org. Biomol. Chem. 2016, 14, 28402845;
22. W. Zhang, J. Wu, B. Li, J. Xia, H. Wu, L. Wang, J. Hao, Q. Zhou, S. Wu, RSC Adv. 2016, 6, 41885–41890.
23. Q. Shi, Y. Li, S. Bo, X. Li, P. Zhao, Q. Liu, Z. Yang, H. Cong, H. Deng, M. Chen, S. Chen, X. Zhou, H. Ding, Z.-X. Jiang, Chem. Commun. 2016, 52, 5136–5139.
24. X. Huang, B. Borgström, L. Månsson, L. Persson, S. Oredsson, C. Hegardt, D. Strand, ACS Chem. Biol. 2014, 9, 15871594.
25. E. F. Paulus, M. Kurz, H. Matter, L. Vértesy, J. Am. Chem. Soc. 1998, 120, 82098221;
26. S. Mronga, F. Riddell, G. Muller, J. Fischer, J. Am. Chem. Soc. 1993, 115, 84148420.
27. M. Mitani, T. Yamanishi, Y. Miyazaki, Biochem. Biophys. Res. Commun. 1975, 66, 1231–1236;
28. Y. Miyazaki, H. Kinashi, N. Ötake, M. Mitani, Agr. Biol. Chem. 1976, 40, 1633–1640.
29. Reaction with salinomycin or its sodium salt either failed to react or gave extensive side product formation.
30. See for example: A. H. Hoveyda, D. A. Evans, G. C. Fu, Chem. Rev. 1993, 93, 13071370.
31. 4 gave a similar selectivity as for 1 a (87:13).
32. Antibiotic SY-Patent JPKaken Chemical Co., Ltd., Japan. 9. 57085390A2, May 28, 1982. Jpn. Kokai Tokkyo Koho.
33. A selective hydrogenation of the olefin has however been reported using Pd(C): H. Asukabe, H. Yoneyama, Y. Mori, K. Harada, M. Suzuki, H. Oka, J. Chromatogr. A 1987, 396, 261271.
34. Calculations and model constructions were performed using the Schrödinger software suite 2014 (version 9.8). Molecular mechanics models were constructed using the OPLS 2005 forcefield.
35. E. F. Paulus, L. Vertesy, Z. Kristallogr. New Cryst. Struct. 2004, 219, 184–186.
36. R. A. De Haan, M. J. Heeg, K. F. Albizati, J. Org. Chem. 1993, 58, 291293.
37. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, M. F. Clarke, Proc. Natl. Acad. Sci. USA 2003, 100, 39833988;
38. C. Sheridan, H. Kishimoto, R. K. Fuchs, S. Mehrotra, P. Bhat-Nakshatri, C. H. Turner, R. Goulet, S. Badve, H. Nakshatri, Breast Cancer Res. 2006, 8, R59. DOI: 10.1186/bcr1610.
39. 25, meaning that concentration needs to be carefully considered when interpreting the results of this assay. See Ref. [12] for details.
40. G. Dontu, W. M. Abdallah, J. M. Foley, K. W. Jackson, M. F. Clarke, M. J. Kawamura, M. S. Wicha, Genes Dev. 2003, 17, 12531270.
41. CCDC 1496546 (11) and 1496545 (12) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre.